Price (delayed)
$94.3
Market cap
$11.12B
P/E Ratio
40.13
Dividend/share
$0.28
EPS
$2.35
Enterprise value
$13.3B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.